Fosamprenavir

In the US, Fosamprenavir (fosamprenavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AE07

CAS registry number (Chemical Abstracts Service)

0226700-79-4

Chemical Formula

C25-H36-N3-O9-P-S

Molecular Weight

585

Therapeutic Categories

Antiviral agent

Treatment of HIV infection

HIV protease inhibitor

Chemical Names

(3S)-tetrahydro-3-furyl [(α S)-α-[(1R)-1-hydroxy-2-(N¹-isobutylsulfanil=amido)ethyl]phenethyl]carbamate, dihydrogen phosphate (ester) (WHO)

(S)-Tetrahydro-3-furyl{(αS)-α-[(R)-1-(dihydroxyphosphoryloxy)-2-(N-isobutylsulfanilamido) ethyl]phenethyl}carbamat (IUPAC)

Foreign Names

  • Fosamprenavirum (Latin)
  • Fosamprenavir (German)
  • Fosamprénavir (French)
  • Fosamprenavir (Spanish)

Generic Names

  • fAPV (IS)
  • GW 433908 (IS: GlaxoSmithKline)
  • VX 175 (IS: Vertex)
  • Fosamprenavir Calcium (OS: USAN)
  • 908 (IS)
  • GW 433908G (IS)
  • VX-175 (IS)

Brand Names

  • Telzer
    GlaxoSmithKline, Mexico
  • Telzir
    GlaxoSmithKline, Colombia; GlaxoSmithKline, Greece; GlaxoSmithKline, Ireland; GlaxoSmithKline, Peru; GlaxoSmithKline, Romania; GlaxoSmithKline, Turkey
  • Levixa
    GlaxoSmithKline, Japan
  • Lexiva
    GlaxoSmithKline, Israel; GlaxoSmithKline, Japan; ViiV Healthcare, United States
  • Telzir
    Glaxo, Latvia; Glaxo Wellcome, Serbia; GlaxoGroup, Netherlands; GlaxoSmithKline, Antigua & Barbuda; GlaxoSmithKline, Argentina; GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Barbados; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bermuda; GlaxoSmithKline, Bahamas; GlaxoSmithKline, Chile; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Grenada; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Iceland; GlaxoSmithKline, Jamaica; GlaxoSmithKline, Cayman Islands; GlaxoSmithKline, Saint Lucia; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Norway; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Trinidad & Tobago; GlaxoSmithKline, South Africa; ViiV, Austria; ViiV, Switzerland; ViiV, United Kingdom; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare ULC, Canada; Viivhiv, Portugal

International Drug Name Search

Glossary

TermDefinition
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web3)